| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 347.45M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TLX returned -9.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +51.3% |
| 1 year | -9.2% |
| All-time high | $18.60 (Jan 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TLX would be worth today ›No. Telix Pharmaceuticals Limited has not paid a dividend in the past 12 months.
Telix Pharmaceuticals Limited stock trades on NASDAQ under the ticker symbol TLX.
Telix Pharmaceuticals Limited is part of the Healthcare sector.
Telix Pharmaceuticals Limited has a market cap of 3.84B USD, based on the latest quote.
